Like some of you, I've been trading ACTC for awhile - about three or four years, back when Bill Caldwell was CEO. As shareholders, we've certainly seen some turbulent times with ACTC. Over these years we've seen some incredible dilution, three different CEOs (interim or otherwise), several bankruptcy scares, and a slew of lawsuits against the company. But somehow, the company has pulled through these challenges. Since Ted has taken the helm, he has been doing a lot of house-cleaning to prepare this company for something big - he's cleaned up and re-stated the financials to ensure their accuracy, resolved the remaining legacy legal issues, and submit ACTC's trial data to a prestigious scientific journal for review.
Just a week or so ago after the A/G case was settled and the last of the legacy legal issues were resolved, we saw the stock tank to a 52 week low and enter the .04's. Today, we're already nearly back into the .06s.
Some traders (particularly keep_investing) are disgruntled because they made the decision to buy and hold this stock through all of these turbulent times and events. Some have traded this stock over the years and have seen both great trades and terrible trades. Regardless of what class of trader you fall into, I want you to completely neglect the past and look at where ACTC stands today and where it's heading.
Today, we have a company that is on the verge of announcing trial results in the near future that, according to various leaked information, is phenomenal. ACTC has (as it's been suggested) developed a treatment that stops AMD dead in its tracks, and often times even improves visual acuity -- 20/400 to 20/40 in at least one case.
We have a company that has no further legacy legal issues and a patent and research portfolio that is industry-leading. The risk of bankruptcy is now lower than its ever been, and the potential for a JV is the highest its been and will likely continue to rise. [continued]
Now that nearly all of the legacy issues are resolved, Ted has only two matters to focus on: Securing a partnership and/or additional financing, and releasing trial results. Both have tremendous upside potential for the stock.
I've honestly never felt better about the future for ACTC and the potential risk/reward ratio that comes with owning this stock. As we sit here in the .05s and as I look at the company as it exists today, I feel that anticipation and speculation alone will cause this stock to continue to rise. With the legacy issues resolved, I feel there's a lot to be excited about as we look forward. And what's better - I see a stock that recently hit a 52 week low but a company that is now at the best point that it's ever been and with a lot to look forward to. To me, this screams "buy, buy, buy!" and I think that as we move forward, excitement will build and we'll start seeing a lot more of it. Trading and/or holding ACTC at these levels and with the company as it stands today simply makes sense.
Why would you assume I've "lost money year after year" on this stock?
And don't be an idiot. This is a RESEARCH company. It was when you bought the stock and you knew it would be for years to come. You knew it was a speculative stock in an emerging field that has yet to fully prosper.
There's a lot you can blame on management, but not trading poorly, conducting due diligence, or your own ignorance.
My confidence in the company has improved greatly. All legacy legal issues resolved, dramatically reduced risk of BK, a major journal reviewing the trial results which we already know are great and pending publication, Ted focused on getting major financing. Cells are more efficient than STEM's and fewer of them are required.
The risk/reward has improved substantially. Buying in the .05s and .06s is such an easy decision.
History repeats itself. Every time ACTC hits a low and the .05s, it bounces back rather quickly.
What's even better - it's near a low with most of the bad news behind us. This low is being produced by GOOD news (AG settlement). Can you have a better buying opportunity?
I heard that Wotton was working on important things like preparing trial results, but the grapevine got to him and he heard that your first demand and highest priority was updating the website with a pic of him. So he put aside trial results and he's been trying to get the perfect picture to make you happy.
If only every past CEO listened to you, we'd have REAL progress!
A few weeks ago the stock was in the low .06's and I made a post speculating that we'd see ACTC edge closer to a 52 week high. We're now sitting in the low to mid .08's and with everything that has developed, we have higher to go. The stock is still far off it's 52 week high but the company is in the best position its ever been in, with all legacy issues taken care of, and with plenty of opportunity for good news pending. I think we'll continue to see this edge higher until we reach that new high....
keep is not a very smart trader. Instead of trading better or realizing his errors, he instead chooses to slam company management.
The stock has been trending upwards for a bit now, and will continue to -- especially with results due out soon. IMO right now is the prime time to buy to get in for trial results.
A company with 30 employees certainly does not need a COO. If you read the writing on the wall, ACTC is likely setting up to be acquired or bought out. There are two possibilities that I can see:
1. The company has already engaged in talks with an interested party to be purchased, and they're setting up shop to be acquired. This situation may or may not be in the best interest of shareholders.
2. ACTC is setting itself up to be put on sale to the best bidder, likely after Phase 1 results are released and blows away the scientific and stem cell community. This could be the best thing that could happen and potentially provide tremendous shareholder value.
As the new CEO stated, it is for temporary financing until a long-term deal is made. When results are released don't be surprised to see all kinds of interest...
STEM has come up with a promising solution, however they use 4x as many cells and they aren't nearly as good as ACTC. ACTC produced a much more effective and efficient solution, IMO.
Bashers will always be bashers, especially when the stock is doing well.
Since your shares are at an average of $0.15 due to terrible trading decisions, do you have a sell order issued for them at $0.15 to recoup your loses? If we hit $0.15, will you go away forever? Or will you "keep" your shares and then complain that we have a terrible CEO if the stock price falls back below $0.15?
Ted Myles did an absolutely fine job as interim, given the circumstances. He was thrown into the position with little to no experience but he managed to clean up so many messes.
I do look very forward to what Wotton will do, and hope that his decisions reflect the best interest of current shareholders.
keep, please look up "extended hours trading" on Wikipedia.. In it, you'll see:
"After-hours trading is trading that occurs after the traditional trading hours of the major exchanges, such as the New York Stock Exchange and the Nasdaq Stock Market. Since 1985, the regular trading hours in the United States have been from 9:30 a.m. to 4:00 p.m. Eastern Time (ET).
After-hours trading on a day with a normal session occurs from 4:00 p.m. to 8:00 p.m. ET."
1. Please note the phrase "major exchanges". No OTC stock is eligible. Yes, some trades WILL show up as "after hours" trades on the Nasdaq site because they weren't fully filled and executed until after the bell, but they were INITIATED within the normal business day. As a result, you will never find an "after hours" trade done with ACTC no more than a minute or two after 4:00pm ET. With major exchange stocks, however, you will, because they are eligible for after hours trading.
Everyone has been trying to tell you that you're wrong for ages. PLEASE don't be one of those idiots who things the entire world is wrong except for him and RESEARCH what you're trying to claim. Yes, I can understand the confusion because Nasdaq shows it on their after hours lookup, but it's NOT a genuine "after hours" trade.
Wotton was at ATRS for the past five years or so. Pull up a chart -- about five years ago, ATRS was worth about $0.72/share. Before he resigned today, the stock was around $3. The stock peaked at over $5. And this is a company that has a pipeline with much less potential than ACTC. Investors clearly like Wotton - let's hope we see similar performance from him with ACTC!